CHRISTY LEE: Open Payments
NPI 1932102605 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 29 payments from 7 companies in 2025. Trend: 2023 $460 · 2024 $784 · 2025 $1,042
Food & beverage: $1,042
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $211 |
| Inspire Medical Systems, Inc. | 6 | $194 |
| GENZYME CORPORATION | 8 | $191 |
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| PFIZER INC. | 1 | $124 |
| Lilly USA, LLC | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
Products named: DUPIXENT, NUCALA, INSPIRE, NURTEC ODT, ZEPBOUND, BREZTRI, TEZSPIRE.
Industry payments across IN — which companies pay providers there.
